Silexion Therapeutics Corp - Ordinary shares, par value $0.0135 per share (SLXN)

Q: What does CUSIP G1281K122 represent in this 13F holders report?

CUSIP G1281K122 is the security identifier for SLXN - Silexion Therapeutics Corp - Ordinary shares, par value $0.0135 per share used to aggregate holder disclosures.

Q: How many institutions held SLXN - Silexion Therapeutics Corp - Ordinary shares, par value $0.0135 per share in Q2 2025?

6 institutional investors reported SLXN - Silexion Therapeutics Corp - Ordinary shares, par value $0.0135 per share for Q2 2025. Use the holders table for investor-level position and value details.

CUSIP: G1281K122

Q2 2025 13F Holders as of 30 Jun 2025

Type / Class: Equity / Ordinary shares, par value $0.0135 per share
Shares outstanding: 3,320,313
Total 13F shares: 281,657
Share change: +45,477
Total reported value: $228,588
Price per share: $0.81
Number of holders: 6
Value change: +$32,523
Number of buys: 3
Number of sells: 1

Quarterly Holders Quick Answers

What is CUSIP G1281K122?
CUSIP G1281K122 identifies SLXN - Silexion Therapeutics Corp - Ordinary shares, par value $0.0135 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2025
Previous quarter: Q1 2025

Recent filing periods for CUSIP G1281K122:

Q3 2025 Q2 2025 Q1 2025 Q4 2024

Institutional Holders of Silexion Therapeutics Corp - Ordinary shares, par value $0.0135 per share (SLXN) as of Q2 2025

As of 30 Jun 2025, Silexion Therapeutics Corp - Ordinary shares, par value $0.0135 per share (SLXN) was held by 6 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 281,657 shares. The largest 6 holders included Wildcat Capital Management, LLC, UBS Group AG, MEYER HANDELMAN CO, Virtu Financial LLC, StoneX Group Inc., and BANK OF AMERICA CORP /DE/. This page lists 6 institutional shareholders reporting positions in this security for the Q2 2025 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.